Paramount Skydance (PSKY) CEO David Ellison on Thursday outlined his vision for the company following the deal to acquire Warner Bros. Discovery Inc. (WBD).Speaking to CNBC, Ellison stated that the transaction could strengthen competition in the media and streaming industry. He emphasized that the combination of major film libraries and stronger financial resources would position the company to compete more effectively in the global entertainment market.“We believe this deal is pro-competitive, pro-consumer, and it is good for the overall creative economy,” he said.Get updates to this developing story directly on Stocktwits.

The Paramount logo is displayed on a mobile phone with the Warner Bros. Discovery icon seen in the background

Paramount Skydance CEO David Ellison Says WBD Deal Positions It To Compete More Effectively Globally: Report

Speaking to CNBC, Ellison stated that the transaction could strengthen competition in the media and streaming industry. 

Equity

Speaking to CNBC, Ellison stated that the transaction could strengthen competition in the media and streaming industry. 


<ul class="summary-bullets"><li>Broadcom CEO Hock Tan stated that the company’s fiscal year 2027 revenue has “dramatically improved” and that the chip designer has a line of sight to more than $100 billion in AI chip revenue.</li><li>Rosenblatt analysts called this the “mic-drop moment” of the earnings call.</li><li>Analysts at JPMorgan hiked their price target to $500 from $475, while keeping an ‘Overweight’ rating, citing continued upside in Broadcom's AI semiconductor segment.</li></ul>Broadcom Inc.’s (STUB) first-quarter (Q1) earnings beat and a better-than-expected guidance for the second quarter (Q2) resulted in a slew of price target hikes from Wall Street.<a href="https://stocktwits.com/symbol/AVGO">Broadcom’s shares</a> were up more than 4% in Thursday’s opening trade. Retail sentiment on Stocktwits around the company trended in the ‘extremely bullish’ territory, with message volumes at ‘extremely high’ levels at the time of writing.<h2 class="st-heading-2">Why Is Wall Street Bullish About AVGO?</h2>According to TheFly, Rosenblatt analysts raised their price target for AVGO stock to $500 from $450 while keeping a ‘Buy’ rating. The firm highlighted that Broadcom’s Q2 guidance surpassed the consensus estimate by 10%, but that was not the only positive.Broadcom CEO Hock Tan stated that the company’s fiscal year 2027 revenue has “dramatically improved” and that the chip designer has a line of sight to more than $100 billion in AI chip revenue. Rosenblatt analysts called this the “mic-drop moment” of the earnings call.Analysts at JPMorgan hiked their price target to $500 from $475, while keeping an ‘Overweight’ rating, citing continued upside in Broadcom's AI semiconductor segment.Similarly, Bernstein hiked its price target for Broadcom to $525 from $475 while keeping an ‘Outperform’ rating. The firm cited Broadcom’s strong Q2 guidance on a much better-than-expected AI outlook as the reason for its target hike.Truist analysts hiked their price target for Broadcom to $545 from $510 while keeping a ‘Buy’ rating. The firm expects Broadcom’s commentary to be interpreted constructively for a broader range of stocks.<h2 class="st-heading-2">Broadcom’s Q1 At A Glance</h2>Broadcom reported earnings per share (EPS) of $2.05 in the first quarter, compared to an EPS of $1.6 during the same quarter a year ago, while Wall Street expected an EPS of $2.02.The company’s revenue in Q1 stood at $19.31 billion, compared to an estimate of $19.14 billion. Broadcom said its AI revenue more than doubled year-on-year to $8.4 billion during the quarter, driven by robust demand for custom AI accelerators and AI networking.For Q2, Broadcom expects revenue of $22 billion, above the consensus estimate of $20.4 billion. AI chip revenue for the quarter is expected to be $10.7 billion.The company also said it entered into a new partnership with OpenAI in Q1 and expects to ship over a gigawatt of compute capacity in 2027.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>One user on the platform praised Broadcom CEO Tan, stating that he focuses the research and development on the company’s highest-margin products.<stembedurl>https://stocktwits.com/Jas45z/message/646666271</stembedurl>Another user stated that Broadcom’s guidance was “absolutely huge.”<stembedurl>https://stocktwits.com/mikekline/message/646644957</stembedurl><a href="https://stocktwits.com/symbol/AVGO">AVGO stock</a> is down 5% year-to-date, but up 72% over the past 12 months.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/merkley-klobuchar-bill-banning-government-officials-from-prediction-markets/cZdQH0rRI3f">Democrat Lawmakers Move To Ban Government Officials From Prediction Markets After Iran, Maduro Bets: Report</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

The Broadcom Ink logo is displayed on a mobile phone in this photo illustration in Brussels, Belgium, on September 2, 2025. 

Broadcom’s Q1 Earnings Beat Has Wall Street Optimistic — Analysts Say This Was The ‘Mic-Drop Moment’

Bernstein hiked its price target for Broadcom to $525 from $475 while keeping an ‘Outperform’ rating, citing the company’s strong second-quarter guidance.

U.S. equities declined in Thursday morning’s trade as the United States-Israel-Iran war entered its sixth day. The Dow Jones Industrial Average tumbled over 400 points at the time of writing, while the S&amp;P 500 index fell 0.1%.Crude oil prices soared on Thursday after Iran said it had struck an oil tanker with a missile in the northern parts of the Persian Gulf. According to a state media&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.tasnimnews.ir/en/news/2026/03/05/3532070/irgc-hits-american-oil-tanker-in-persian-gulf">report</a>, the tanker struck by the IRGC Navy was on fire at the time of writing.U.S. West Texas Intermediate (WTI) crude futures maturing in April soared nearly 5% on Thursday, rising to $78.36 per barrel, compared to the previous closing price of $74.66. Brent crude futures maturing in May gained 3%, rising to $83.75 per barrel."The U.S. International Development Finance Corporation would need to have some creative operational changes, including the ability to operate in the Middle East, a shift from project-based financing to shipping, and would need a significant acceleration in approvals from the typical six-to-nine month process," said Michelle Gibley, director of international equity research and strategy, Schwab Center for Financial Research.Gibley added that despite President Donald Trump's extension of risk insurance, concerns about crew safety could limit the level of risk associated with shipping oil through the Strait of Hormuz.The CNN Fear and Greed Index&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://edition.cnn.com/markets/fear-and-greed">was</a> hovering in the ‘Fear’ zone at 38.At the time of writing, the&nbsp;<a href="https://stocktwits.com/symbol/SPY">SPDR S&amp;P 500 ETF</a> (SPY), which tracks the S&amp;P 500 index, was down 0.13%; the&nbsp;<a href="https://stocktwits.com/symbol/QQQ">Invesco QQQ Trust ETF</a> (QQQ) rose 0.16%; and the&nbsp;<a href="https://stocktwits.com/symbol/DIA">SPDR Dow Jones Industrial Average ETF Trust</a> (DIA) declined 0.81%. Retail sentiment on Stocktwits regarding the S&amp;P 500 ETF was in the ‘neutral’ territory.Get updates to this story developing directly on Stocktwits.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/merkley-klobuchar-bill-banning-government-officials-from-prediction-markets/cZdQH0rRI3f">Democrat Lawmakers Move To Ban Government Officials From Prediction Markets After Iran, Maduro Bets: Report</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

The New York Stock Exchange stands on Wall Street in New York City

Dow Tumbles Over 400 Points, Crude Oil Prices Soar After Iran Says It Hit An Oil Tanker – Escalating US-Israel-Iran War Enters 6th Day

U.S. West Texas Intermediate crude futures maturing in April soared nearly 5% on Thursday, rising to $78.36 per barrel.

<ul class="summary-bullets"><li>Mobix Labs said it will supply components that help protect Gulfstream aircraft electronics from electromagnetic interference.</li><li>Management expects more Gulfstream deals to follow the production purchase orders.</li><li>MOBX shares closed around 533% higher on Tuesday on securing a production order for components used in the U.S. Navy’s Tomahawk cruise missile program.</li></ul>Mobix Labs Inc. (MOBX) generated retail buzz yet again, as the stock gained around 30% on Thursday after the company announced it had received new production purchase orders for electronic components used in Gulfstream aircraft.This follows a massive rally on Tuesday, when <a href="https://stocktwits.com/symbol/MOBX">MOBX shares</a> closed around 533% higher after the company <a href="https://stocktwits.com/news-articles/markets/equity/why-did-mobx-stock-soar-pre-market-today/cZdeW5hRIPI">announced</a> a production order for components used in the U.S. Navy’s Tomahawk cruise missile program.<h2 class="st-heading-2">Mobix To Supply Components To Block Electromagnetic Interference</h2>Mobix Labs said the orders are tied to ongoing aircraft production and will support near-term manufacturing schedules. The components help protect aircraft electronics from electromagnetic interference and ensure operations of systems such as navigation, communications, and avionics.“Mobix Labs is already integrated into Gulfstream aircraft programs, and as aircraft production continues, new orders for our proven high-reliability components typically follow,” said Phil Sansone, CEO of Mobix Labs.Gulfstream aircraft are manufactured by Gulfstream Aerospace, a unit of the NYSE-listed <a href="https://stocktwits.com/symbol/GD">General Dynamics</a> (GD).<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>The stock has been in the spotlight lately, with retail sentiment on Stocktwits remaining ‘extremely bullish’ since the Tomahawk program order on Tuesday. Chatter on the platform has been ‘extremely high’ too.<img src="https://news.stocktwits-cdn.com/MOBX_jpg_06c2794c04.webp" alt="MOBX.jpg">One user believes additional deals may already be in the pipeline.<stembedurl>https://stocktwits.com/Rod92/message/646668865</stembedurl>Another user expects the next parabolic small-cap stock move could come from a low-float defense company like Mobix.<stembedurl>https://stocktwits.com/SpudZone/message/646669829</stembedurl>A bullish user said the stock may see a 10x jump in the short term.<stembedurl>https://stocktwits.com/newsychatter/message/646666832</stembedurl>Around 145 million shares changed hands within half an hour of the opening bell on Thursday, compared to an average volume of around 27 million, according to Stocktwits data.<h2 class="st-heading-2">Mobix’s Defense Push</h2>Mobix Labs has been increasingly expanding its presence in the defense market. The company’s technologies are already used in major military platforms, including the F-22 Raptor fighter jet, Apache helicopters, and missile systems.On Tuesday, the company said it will supply filtering components that protect onboard electronics from electromagnetic interference in the Tomahawk cruise missile, a long-range U.S. military weapon typically launched from Navy ships and submarines.Last month, Mobix Labs received FAA certification for its next-generation drone-based airborne sensing platform.Year-to-date, the stock has gained 280%.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/usa-rare-earth-texas-mineral-73-million-round-top-deal/cZdQrvNRI3d">USA Rare Earth Makes $73 Million Bid For Texas Mineral To Develop Round Top Rare Earth Project</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Mobix Labs logo is seen displayed on a smartphone screen.

This Highly Traded Micro-Cap Electronics Stock Surged 30% Today – Retail Expects 10x Growth

Mobix Labs said it received new production purchase orders for electronic components used in Gulfstream aircraft.

MOBX Stock Jumps 30% Just Days After A Six-Fold Surge – Retail Sees Parabolic Run

<ul class="summary-bullets"><li>CorMedix’s Q4 revenue included $91.2 million from DefenCath sales and $37.4 million from the Melinta portfolio.</li><li>Total operating expenses for Q4 rose to $48.2 million, up 181% year-on-year.</li><li>CorMedix ended 2025 with $148.5 million in cash, cash equivalents, and short-term investments.</li></ul>CorMedix Inc. (CRMD) stock gained attention on Thursday, after the company announced its fourth-quarter (Q4) and full-year financial results for 2025, reporting a 312% year-on-year (YoY) jump in revenue.&nbsp;The company reported Q4 revenue of $128.6 million and an earnings per share (EPS) of $0.16. Though CorMedix’s revenue surpassed analysts’ consensus estimate of $127 million, EPS came in way below the estimated $0.82, according to Fiscal AI data.&nbsp;<h2 class="st-heading-2">What Are Stocktwits Users Saying?&nbsp;</h2><a href="https://stocktwits.com/symbol/CRMD">CorMedix stock</a> traded over 11% lower on Thursday morning. However, on Stocktwits, retail sentiment around the stock flipped to ‘bullish’ from ‘bearish’ territory the previous day. Message volume shifted to ‘high’ from ‘low’ in 24 hours.&nbsp;<figure class="image"><img src="https://news.stocktwits-cdn.com/Screenshot_2026_03_05_092009_png_aaa43e3104.webp" alt="CRMD’s Sentiment Meter and Message Volume as of 09:50 a.m. ET on Mar. 5, 2026 | Source: Stocktwits" width="930" height="102"><figcaption>CRMD’s Sentiment Meter and Message Volume as of 09:50 a.m. ET on Mar. 5, 2026 | Source: Stocktwits</figcaption></figure>A Stocktwits user said they are going long on the stock and hope to keep it until it climbs back to double digits.<stembedurl>https://stocktwits.com/JamesTiberius/message/646666139</stembedurl><h2 class="st-heading-2">Revenue Growth Driven by DefenCath and Melinta Acquisition</h2>CorMedix’s Q4 revenue included $91.2 million from DefenCath sales and $37.4 million from the Melinta portfolio. The Melinta revenue reflects the company’s first full quarter of contribution since its August 2025 acquisition.&nbsp;Total operating expenses for Q4 rose to $48.2 million, up 181% YoY. The expense increase primarily stems from the Melinta acquisition and includes $4.1 million in one-time costs, such as severance and integration expenses.&nbsp;<blockquote>“I am proud of the company’s progress over the past year as we have accelerated the expansion of patient access for DefenCath, completed our acquisition and integration of Melinta, and saw progress in our two ongoing Phase 3 clinical programs for Rezzayo prophylaxis and DefenCath in TPN.”-Joe Todisco, Chairman and CEO, CorMedix&nbsp;</blockquote>CorMedix ended 2025 with $148.5 million in cash, cash equivalents, and short-term investments, excluding restricted cash.CRMD stock has declined by over 37% in the last 12 months.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/help-stock-tanks-despite-strong-phase-2-results-for-anxiety-treatment-retail-buys-the-dip-ignoring-market-s-pessimism/cZdQHEpRI3O">HELP Stock Tanks 22% Despite Strong Phase 2 Results For Anxiety Treatment: Retail Buys The Dip Ignoring Market’s Pessimism</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the CorMedix logo is seen displayed on the screen of a tablet. (Photo Illustration by Sheldon Cooper/SOPA Images/LightRocket via Getty Images)

Why Did CRMD Stock Tumble Over 11% Today?

The company reported mixed Q4 results with a revenue of $128.6 million and earnings per share of $0.16. 

<ul class="summary-bullets"><li>Senator Jeff Merkley stated that he first became concerned about prediction markets after a bettor on Polymarket won more than $400,000 by accurately predicting that the U.S. would remove Maduro.</li><li>He added that it was “extraordinarily likely” that somebody in the group of people who knew about the U.S. action leaked the information to a bettor on the prediction platform.</li><li>A New York Times analysis found more than 150 Polymarket accounts placed bets of over $1,000 predicting last Saturday’s U.S.–Israel strikes on Iran a day early.</li></ul>Democratic lawmakers&nbsp;led by Senators Jeff Merkley and Amy Klobuchar are reportedly set to introduce a bill banning the President, Vice President, and members of Congress from placing bets on prediction markets.According to a CNBC&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.cnbc.com/2026/03/05/prediction-markets-merkley-ban-iran.html">report</a>, the bill also seeks to ban senior executive branch officials from prediction markets, with fines starting at $10,000 for those found in violation of the rules.The bill comes at a time when major international events, such as the ouster of former Venezuelan President Nicolas Maduro and the Iran war, have seen bets placed on prediction markets such as Kalshi and Polymarket.“Members receive all sorts of tips and advice. The actual demonstration of insider trading is too difficult to be sufficient to address the problem. The problem becomes both real corruption … and the appearance of corruption and conflict of interest,” Merkley said during the interview.<h2 class="st-heading-2">The Venezuela Bet That Made Merkley Suspicious</h2>Merkley stated that he first became concerned about prediction markets after a bettor on Polymarket won more than $400,000 by accurately predicting that the U.S. would remove Maduro.“That was a case where you had the secretary of state saying ‘we didn’t notify Congress the way we’re supposed to under the law because we were too concerned about a leak,’” Merkley said during the interview.He added that it was “extraordinarily likely” that somebody in the group of people who knew about the U.S. action leaked the information to a bettor on the prediction platform.“This legislation strengthens the Commodity Futures Trading Commission’s ability to go after bad actors and provides rules of the road to prevent those with confidential government or policy information from exploiting their access for financial gain,” Sen. Klobuchar said in a statement to CNBC.<h2 class="st-heading-2">Soaring Popularity Of Prediction Markets</h2>According to an&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.nytimes.com/2026/03/03/upshot/prediction-markets-iran-strikes.html">analysis</a> by The New York Times, a day before the joint U.S.-Israel strikes on Iran Saturday last week, more than 150 accounts placed bets of at least $1,000 on Polymarket, accurately predicting attacks on the Middle Eastern country.The analysis also showed that at least 16 accounts profited by more than $100,000 each, while at least 109 accounts made more than $10,000.One user reportedly took home nearly half a million dollars after placing bets worth over $60,000.<h2 class="st-heading-2">Israeli Army Reservists Arrested Over Suspicion Of Using Classified Information</h2>Earlier in February, the Israeli authorities arrested several army reservists and a civilian over suspicion of using classified information to place bets on an online prediction platform.Israeli authorities said that the charges came after an investigation into suspected gambling “based on classified information to which the reservists were exposed by virtue of their role in the army,” according to a&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.nytimes.com/2026/02/12/world/middleeast/israel-army-reservists-classified-information-bets.html">report</a> by The New York Times.Meanwhile, U.S. equities declined in Thursday’s pre-market trade. At the time of writing, the&nbsp;<a href="https://stocktwits.com/symbol/SPY">SPDR S&amp;P 500 ETF</a> (SPY), which tracks the S&amp;P 500 index, was down 0.43%; the&nbsp;<a href="https://stocktwits.com/symbol/QQQ">Invesco QQQ Trust ETF</a> (QQQ) fell 0.56%; and the&nbsp;<a href="https://stocktwits.com/symbol/DIA">SPDR Dow Jones Industrial Average ETF Trust</a> (DIA) declined 0.72%. Retail sentiment on Stocktwits regarding the S&amp;P 500 ETF was in the ‘neutral’ territory.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/berkshire-hathaway-ceo-greg-abel-purchases-15-million-stock/cZdQtjDRI34">Berkshire Hathaway CEO Greg Abel Loads Up On $15M In Stock, BRK Resumes Share Buybacks</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Sen. Jeff Merkley, D-Ore., speaks during the Senate Democrats' news conference in the U.S. Capitol

Democrat Lawmakers Move To Ban Government Officials From Prediction Markets After Iran, Maduro Bets: Report

The bill comes at a time when major international events, such as the ouster of former Venezuelan President Nicolas Maduro and the Iran war, have drawn bets on prediction markets such as Kalshi and Polymarket.

<ul class="summary-bullets"><li>The clinical trial included 36 participants who continued taking existing medications for generalized anxiety disorder while receiving HLP004 injections.</li><li>Researchers administered two doses three weeks apart and monitored participants for 12 weeks.</li><li>Six months after treatment, about 67% of the combined study group met the criteria for a clinical response.</li></ul>Helus Pharma (HELP) announced encouraging early-stage clinical results for its experimental anxiety treatment HLP004 on Thursday, reporting notable symptom improvement among patients with moderate-to-severe generalized anxiety disorder.&nbsp;The clinical-stage drug developer said its Phase 2 signal detection trial showed statistically meaningful improvements when the therapy was used alongside standard antidepressant treatments.&nbsp;<h2 class="st-heading-2">Trial Demonstrates Significant Anxiety Reduction</h2>In the study, participants receiving a 20-milligram dose of HLP004 alongside standard-of-care treatment experienced an average drop of roughly 10.4 points on the Hamilton Anxiety Rating Scale after six weeks.&nbsp;The clinical trial included 36 participants who continued taking existing medications for generalized anxiety disorder while receiving HLP004 injections. Researchers administered two doses, three weeks apart, and monitored participants for 12 weeks, with additional follow-up planned for up to 1 year.<a href="https://stocktwits.com/symbol/HELP">Helus Pharma stock</a> traded over 22% lower in Thursday’s remarket.&nbsp;<h2 class="st-heading-2">Long-Lasting Response Observed In Many Patients</h2>The company also reported sustained benefits beyond the initial treatment period. Six months after treatment, about 67% of the combined study group met the criteria for a clinical response, while 39% reached remission.Among those receiving the higher 20-milligram dose, 59% showed improvement and 32% achieved remission after six weeks. In the lower-dose group, about 30% of patients met response and remission benchmarks at the same time point.<h2 class="st-heading-2">What Are Stocktwits Users Saying?&nbsp;</h2>Despite the stock’s decline in the premarket session, retail sentiment on Stocktwits around the stock flipped to ‘extremely bullish’ from ‘neutral’ territory the previous day. Message volume shifted to ‘high’ from ‘normal’ levels in 24 hours.&nbsp;<figure class="image"><img src="https://news.stocktwits-cdn.com/Screenshot_2026_03_05_083359_png_25a9744605.webp" alt="HELP’s Sentiment Meter and Message Volume as of 08:30 a.m. ET on Mar. 5, 2026 | Source: Stocktwits" width="925" height="96"><figcaption>HELP’s Sentiment Meter and Message Volume as of 08:30 a.m. ET on Mar. 5, 2026 | Source: Stocktwits</figcaption></figure>A Stocktwits user said they have bought the dip.&nbsp;<stembedurl>https://stocktwits.com/Jimbob3016/message/646658779</stembedurl>HELP stock has gained over 4% year-to-date.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/liquidia-stock-gains-premarket-on-q4-revenue-beat-investors-are-betting-on-yutrepia-growth/cZdQrwNRI33">Liquidia Stock Gains Premarket On Q4 Revenue Beat – Investors Are Betting On YUTREPIA Growth</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Rising stock market chart on a trading board background.

HELP Stock Tanks 22% Despite Strong Phase 2 Results For Anxiety Treatment: Retail Buys The Dip Ignoring Market’s Pessimism

In the study, participants receiving a 20-milligram dose of HLP004 alongside standard-of-care treatment experienced an average drop of roughly 10.4 points on the Hamilton Anxiety Rating Scale after six weeks. 

Shares of Gaxos.ai (GXAI) surged more than 85% in pre-market trading on Thursday after the company said America First Defense, in which it holds a 20% stake, secured a license for the Detachable Drone Highjacker, a drone-mounted electronic warfare system designed to counter hostile drones.The Detachable Drone Highjacker operates by attaching to a friendly drone to target and neutralize enemy unmanned aircraft systems through cyber operations rather than traditional signal jamming.Under the licensing agreement, America First Defense plans to further develop and commercialize the technology for defense, security, and critical infrastructure protection applications.Get updates to this developing story on Stocktwits.For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Gaxos AI logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

Why Did GXAI Stock Surge Over 85% In Pre-Market Today?

America First Defense, a company in which Gaxos holds a 20% stake, secured a license for a drone-mounted electronic warfare system.

<ul class="summary-bullets"><li>Analysts at JPMorgan downgraded StubHub to ‘neutral’ from ‘overweight’ while reducing the price target to $10 from $12.</li><li>The firm cited StubHub’s guidance reset for 2026 as the reason for the downgrade, while highlighting that the company will need to build credibility with investors.</li><li>Wedbush stated that it has “limited conviction and visibility” regarding StubHub’s direct issuance business.</li></ul>StubHub Holdings Inc.’s (STUB) lackluster fourth-quarter (Q4) results drew a spate of downgrades from Wall Street, with analysts pointing to a series of concerns about the company’s future outlook and the regulatory environment.<a href="https://stocktwits.com/symbol/STUB">StubHub shares</a> tumbled more than 14% in Thursday’s pre-market trade. Retail sentiment on Stocktwits around the company trended in the ‘extremely bullish’ territory at the time of writing.<h2 class="st-heading-2">Why Is Wall Street Worried?</h2>Analysts at JPMorgan downgraded StubHub to ‘neutral’ from ‘overweight’ while reducing the price target to $10 from $12. The firm cited StubHub’s guidance reset for 2026 as the reason for the downgrade, while highlighting that the company will need to build credibility with investors.JPMorgan stated that StubHub’s 2026 earnings before interest, taxes, depreciation, and amortization (EBITDA) guidance is now 60% lower than what the company projected in October 2025. The firm said that while the new outlook “may finally be achievable,” it will have to work through the lock-up expiration beginning March 9, 2026, and also overcome ongoing regulatory concerns around the company.Analysts at Wedbush also downgraded StubHub to ‘neutral’ from ‘outperform’ and lowered the price target by 80% to $10 from $18. The firm stated that it has “limited conviction and visibility” in StubHub’s direct issuance business, noting that the ticket resale broker’s management’s “lofty” expectations are not materializing.Wedbush also stated that regulatory risks will remain an overhang on the stock, while adding that the company is vulnerable to AI-enabled disintermediation in the coming years, given that companies operating in the space face the risk from commoditization.<h2 class="st-heading-2">StubHub’s Q4 At A Glance</h2>StubHub reported a loss of $1.56 per share in Q4, compared to earnings per share (EPS) of $0.13 during the same quarter a year ago. Wall Street expected the company to report a loss of $0.02 per share during the quarter, according to Fiscal.ai data.The company’s revenue in Q4 was $449 million, down from $533 million in the year-ago period. Wall Street consensus projected StubHub to report revenue of $485 million during the period.StubHub’s founder and CEO, Eric Baker, remained optimistic about the company’s prospects, stating that 2025 reinforced that the ticket resale broker’s mission is as relevant as ever. “Our full-year performance validates our long-term strategy and the substantial value we're creating for fans, partners, and shareholders alike,” he said.<h2 class="st-heading-2">How Did Stocktwits Users React To STUB?</h2>One user on Stocktwits pointed to macroeconomic challenges in the U.S., adding that the amount of money people have to spend on “luxuries” is declining.<stembedurl>https://stocktwits.com/insanitywolftrading/message/646656600</stembedurl>However, a bullish user said that StubHub is a “solid company with actually great earnings.”<stembedurl>https://stocktwits.com/llevi/message/646632021</stembedurl><a href="https://stocktwits.com/symbol/STUB">STUB stock</a> is down 25% year-to-date and 64% over the past 12 months.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/pdyn-stock-soars-q4-beat-palladyne-ai-ceo-touts-deeper-defense-engagement/cZdQqg1RI3P">Palladyne AI CEO Touts Expanded Backlog, Deeper Defense Engagement After Q4 Beat Sends PDYN Stock Soaring</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

The StubHub logo and webpage are displayed on a cell phone and computer monitor. (Photo Illustration by Mario Tama/Getty Images)

StubHub's Q4 Miss Draws Multiple Downgrades From Wall Street – Analysts Warn Of ‘Credibility’ Gap

StubHub reported a loss of $1.56 per share in Q4, compared to earnings per share of $0.13 during the same quarter a year ago, while Wall Street expected a loss of $0.02 per share.

<ul class="summary-bullets"><li>Under the revised agreement, the combined public company will issue around 169.6 million ordinary shares.</li><li>The combined public company will also issue 128,000 shares to DSS, its parent company.</li><li>This follows a June 2025 agreement to combine Dr Ashleys’ manufacturing with Impact BioMedical’s portfolio of more than 90 medical patents.</li></ul>Shares of Impact BioMedical (IBO) soared over 65% in pre-market trading on Thursday, after the company announced amendments to agreements tied to its planned merger with Dr Ashleys.If the pre-market level holds after the opening bell, <a href="https://stocktwits.com/symbol/IBO">IBO stock</a> would hit its highest since Sept. 12, 2025.<h2 class="st-heading-2">PubCo To Issue 169.6 Million Shares</h2>Under the revised agreement, the combined public company, referred to as PubCo, will issue 169,560,000 ordinary shares, which represent about 94.2% of PubCo’s outstanding shares at the closing of the business combination. These shares are called the Company Share Consideration.PubCo will issue 22,000 shares to Impact’s CEO, Frank D. Heuszel, and up to 128,000 shares to DSS in two batches. DSS is the parent company of Impact BioMedical. These shares will be&nbsp;deducted from the PubCo’s Company Share Consideration.Additionally, the deadline to complete the merger was extended from March 31, 2026, to July 1, 2026, while shareholders who support the transaction currently control about 88.9% of Impact BioMedical’s shares.<h2 class="st-heading-2">Merger To Open Up Manufacturing Access For Impact</h2>In June 2025, Impact BioMedical and Dr Ashleys signed a definitive merger agreement with Dr Ashleys. The transaction will create a new holding company that will own both Dr Ashleys and Impact BioMedical as subsidiaries. The combined company will be led by Dr Ashleys’ executive team and a newly appointed board.The merger aims to combine Dr Ashleys’ manufacturing and global market access with Impact BioMedical’s portfolio of more than 90 patents covering treatments for cancer, infectious diseases, respiratory illnesses, and orphan drugs.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>The stock garnered significant retail buzz, with Stocktwits data indicating a 14,200% increase in message volumes over the past 24 hours, while retail sentiment on the platform turned ‘extremely bullish’ from ‘bullish’ a day back.<img src="https://news.stocktwits-cdn.com/ibo_jpg_729ebe600c.webp" alt="ibo.jpg">One user sees a rally if the stock breaks over $0.8. It is currently at $0.69.<stembedurl>https://stocktwits.com/TroubleMaker/message/646636004</stembedurl>Another user sees the stock climbing to the $2.45 - $3 range.<stembedurl>https://stocktwits.com/Flybeast/message/646657749</stembedurl>Year-to-date, the stock has gained around 36%.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/why-did-btai-stock-surge-in-pre-market-today/cZdQs29RI3E">Why Did BTAI Stock Surge 20% In Pre-Market Today?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Why Did IBO Stock Surge 65% In Pre-Market Today?

The company announced amendments to agreements related to its planned merger with Dr. Ashley's, including extending the deadline to complete the merger to July 1, 2026.

IBO Stock Spikes Pre-Market: Retail Traders Pile Into Biotech Penny Stock After Merger Update

SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. It operates through the United States and International geographical segments. The firm offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

The Trade Desk is trending as its CEO made a significant insider stock purchase, signaling strong confidence, while rumors of a potential partnership with OpenAI to sell ads are igniting community speculation about a major growth catalyst for the recently oversold ad-tech stock.

Battalion Oil Corp. engages in the acquisition, production, exploration, and development of liquids-rich oil and natural gas assets in the Delaware Basin. The company was founded in 1987 and is headquartered in Houston, TX.

Battalion Oil Corp - Ordinary Shares (New)

Battalion Oil is experiencing extreme volatility and massive trading volume as escalating Middle East tensions and concerns over oil supply routes drive crude prices higher. The community is actively debating the stock's short squeeze potential, with bullish traders eyeing significant upside while others caution about profit-taking and its recent offering price.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

Escalating US-Iran tensions and concerns over the critical Strait of Hormuz are driving USO, with community debate sharply divided between expectations of prolonged supply disruptions and significant oil price increases versus anticipation of a rapid de-escalation and market interventions.

Palladyne AI Corp. engages in the design, development, and manufacture of industrial robotic systems that augment human performance by combining human intelligence, instinct, and judgment with the strength, endurance, and precision of machines to enhance employee safety and productivity. Its products include Palldyne IQ and Palladyne Pilot. The company was founded by Fraser M. Smith and Benjamin G. Wolff in 2015 and is headquartered in Salt Lake City, UT.

Palladyne AI Corp.

Palladyne AI Corp. is trending following its strong Q4 earnings report, reaffirming impressive future revenue growth guidance, and securing significant new defense contracts including missile propulsion systems and multi-domain swarming autonomy projects. The community is actively discussing the company's potential as a transformative player in defense AI and drone technology, with many likening it to early-stage industry leaders, further amplified by high short interest and expectations for a major upside move.

Cybin, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.

Helus Pharma Inc.

Helus Pharma is trending following a significant stock drop after releasing Phase 2 data for its HLP004 GAD treatment, sparking community debate over the trial's mixed efficacy signals and whether the market is overreacting to what the company frames as clinically meaningful results.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

CorMedix is trending following its Q4 results and reaffirmed conservative 2026 guidance, which has ignited widespread community frustration over perceived management missteps and undervaluation. Despite the board authorizing a share buyback aimed at boosting value and potentially combating persistent short interest, investors are keenly awaiting upcoming Rezzayo data and new customer partnerships as crucial catalysts.

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull is trending following its Q4 earnings, which initially saw confusion over EPS figures before being clarified as an inline beat with robust revenue growth and record customer assets. The community is sharply divided, debating whether ongoing dilution concerns and historical stock performance outweigh these strong operational metrics, with many perceiving the stock as deeply undervalued in the fintech brokerage space.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and fibre channel storage area networking business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom is trending following a strong earnings report that exceeded expectations and significantly raised future guidance, fueled by robust demand for its AI chips and a new partnership with OpenAI. The company's optimistic forecast for AI revenue is sparking intense discussion, with many anticipating continued growth, while some express caution about valuation and broader market conditions affecting the post-earnings momentum.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

Rigetti Computing (RGTI) is trending after a recent earnings report revealed low revenue and substantial losses, intensifying community debate over its high market valuation. While many express strong skepticism about the company's financials, a segment of investors remains long-term bullish on its quantum computing potential and existing cash reserves.

Indonesia Energy Corp. Ltd. operates as an oil and gas, exploration, and production company. It engages in oil and gas assets portfolio with a mix between medium-sized producing blocks and exploration blocks with significant resources. Its portfolio includes Kruh, Citarum, and Rangkas Area. The company was founded by James J. Huang and Wirawan Jusuf in 2014 and is headquartered in Jakarta, Indonesia.

Indonesia Energy Corp Ltd

Indonesia Energy Corp Ltd ($INDO) is trending amidst sharply rising crude oil prices and escalating geopolitical tensions threatening global oil supply, leading the community to anticipate a significant short squeeze. Many investors are drawing parallels to its explosive 2022 run, eagerly awaiting drilling updates as they navigate concerns about market manipulation and potential dilution.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


News